URGN (UroGen) Yalpi foyda marjasi

URGN (UroGen Pharma Ltd) - kompaniyaning tovar belgisi

UroGen Pharma Ltd. (URGN) mahsulotlarining xalqaro jo'natmalari tasdiqlangan operatorlar orqali amalga oshiriladi, bu esa ta'minot zanjiri barqarorligini ta'minlaydi. Valo martaba tarixi GURU.Markets grafik ma'lumotlaridan olingan bo'lib, u yerda 91.40 qiymati ushbu samaradorlik ko'rsatkichini aks ettiradi. Kompaniyaning daromadlari buyrak va qovuq saratoni uchun patentlangan terapiyalarning sotuviga asoslangan. Biznes salohiyati uroteliumni mahalliy davolash uchun innovatsion RTGel gidrogellerini ishlab chiqishga tayanadi.

URGN - urogen.com Yalpi foyda bo'yicha rentabellik 04.07.2022 - 20.11.2026 oraligʻida

UroGen Pharma Ltd. (URGN) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor narxi va tahlilchilarning maqsadli narxlari:
Fundamental baholash:UroGen Pharma Ltd.
UroGen Pharma Corp tovar namunasi

Yalpi foyda marjasi bevosita mahsulot xarajatlarini chegirib tashlagandan keyin qolgan daromad qismini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi va bu har bir birlikning fundamental daromadliligini baholash imkonini beradi. Tarixiy yalpi foyda marjalarini tahlil qilish orqali investor UroGen Pharma Ltd. (URGN) gel formulalari daromadliligini baholashi mumkin, bu esa Jelmyto monetizatsiyasini tahlil qilish va UGN-102 bozorga chiqarilishi davrida operatsion xarajatlarni nazorat qilish uchun juda muhimdir.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|Bicara Therapeutics - Yalpi foyda bo'yicha rentabellik|Yalpi marja Personalis Inc PSNL|Erasca Oncology - Yalpi marja|Yalpi foyda normasi DCTH (Delcath Corp)|YMAB: Yalpi marja|AURA - Yalpi foyda bo'yicha sotuv rentabelligi|CADL (Candel Therapeutics Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi ARAY (Accuray)|Yalpi foyda bo'yicha rentabellik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Yalpi foyda marjasi|Yalpi rentabellik Citius Oncology, Inc. CTOR|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik